|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Corporate social responsibility: attributions, loyalty, and the mediating role of trust显示文摘 | Pavlos A. Vlachos Argiris Tsamakos Adam P. Vrechopoulos Panagiotis K. Avramidis | 2009 | Journal of the Academy of Marketing Science2009，，2： | 2 |
| 2 | Gefitinib as first-line compassionate use therapy in patients with advanced non-small-cell lung cancer 显示文摘 | Argiris A Mittal N | 2004 | Lung Cancer2004，43，3： | 1 |
| 3 | Corporate Social Responsibility:Attributions, Loyalty and the Mediating Role of Trust 显示文摘 | Pavlos A Vlachos Argiris Tsamakos Adam P Vrechopoulos Panagiotis K Avramidis | 2009 | Journal of the Academy of Marketing Science2009，，37： | 1 |
| 4 | Esthesioneuroblastoma:the Northwestern University experience显示文摘 | Argiris A Dutra J Tseke P | 2003 | Laryngoscope2003，113，1： | 1 |
| 5 | Combined analysis of molecular and clinical predictors of Gefitinib activity in advanced non - small cell lung cancer: Epidermal growth factor receptor mutations do not tell the whole story显示文摘 | Athanassios Argiris | 2006 | J Thorac Oncol2006，1，： | 1 |
| 6 | Advances in chemotherapy for small cell lung cancer:single-agent activity of newer agents 显示文摘 | Murren JR | 2001 | Cancer J2001，7，3： | 1 |
| 7 | Progress in the therapy of small cell lung cancer显示文摘 | Simon M Argiris A Murren JR | 2004 | Crit Rev Oncol Hematol2004，49，2： | 1 |
| 8 | Head and neck cancer显示文摘 | Argiris A Karamouzis MV Raben D | 2008 | Lancet2008，371，9625： | 1 |
| 9 | Docelaxel and irinolecan, alone and in combination, in the treatment of non-small cell lung cancer 显示文摘 | Adjei AA Argiris A Murren JR | 1999 | Sere in Oncol1999，26，6： | 1 |
| 10 | A phase Ⅱ trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer 显示文摘 | Argiris A Cohen E Karrison T | 2006 | Cancer Biol Ther2006，5，7： | 1 |
| 11 | Phase Ⅱ trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer显示文摘 | ARGIRIS A KARAMOUZIS M V GOODING W E | | 0，，09： | 1 |
| 12 | Cetuximab and bevacizumab:preclinical data and phaseⅡtrial in recurrent or metastatic squamous cell carcinoma of the head and neck显示文摘 | Argiris A Kotsakis AP Hoang T | 2013 | Ann Oncol2013，24，1： | 1 |
| 13 | Splenic and renal infarctions complicating atrial fibril Iation显示文摘 | Argiris A | 1997 | Mt Sinai J Med1997，64，4： | 1 |
| 14 | Active solar space heating of residential buildings i northem hellas-a case study显示文摘 | Argiriou A Klitsikas N Balaras C A | 1997 | Energy and Buildings1997，26，2： | 1 |
| 15 | Docetaxel and irinotecan, alone and in combinnatiom, in the treatment of non - small cell lung cancer 显示文摘 | Adjei AA Argiris A Murren Jr | 1999 | Semin Oncol1999，26，5： | 1 |
| 16 | Green tea, white tea, and Pelargonium purpureum increase the antioxidant capacity of plasma and some organs in mice 显示文摘 | Antonios E Koutelidakis Konstantina Argiri Mauro Serafini | 2009 | Nutrition2009，25，4： | 1 |
| 17 | Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy 显示文摘 | Argiris A Brockstein BE Haraf DJ | 2004 | Clin Cancer Res2004，10，6： | 1 |
| 18 | Progress in the therapy of small Cell lung cancer显示文摘 | Simon M Argiris A Murren JR | 2004 | Crit Rev Oncol Hematol2004，49，2： | 1 |
| 19 | Potential for energy conservation in apartment buildings显示文摘 | BALARAS C A DROUTSA K ARGIRIOU A A Asimakopoulos D N | 2000 | Energy and Buildings2000，31，2： | 1 |
| 20 | Epidemiology,staging and screening of head and neck cancer显示文摘 | ARGIRIS A ENG C | 2003 | Cancer Treatment Res2003，114，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员